Last updated on August 2018

Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease


Brief description of study

This study will evaluate higher versus standard adalimumab dosing regimens for induction and maintenance therapy in subjects with moderately to severely active Crohn's Disease and evidence of mucosal ulceration.

Clinical Study Identifier: NCT02065570

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Commonwealth Clinical Studies /ID# 136850
Brockton, MA United States
2.56miles
  Connect »